Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    06X131E4OE

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pfizer's Braftovi Regimen Nearly Doubles PFS in mCRC
    Pfizer's Braftovi Regimen Nearly Doubles PFS in mCRC

    31 May 2026

    // PRESS RELEASE

    https://www.pfizer.com/news/press-release/press-release-detail/pfizers-braftovi-regimen-nearly-doubles-median-progression

    PRESS RELEASE
    31 May 2026
    Share Share
    Venus Remedies Secures New Drug Authorizations In Vietnam
    Venus Remedies Secures New Drug Authorizations In Vietnam

    09 Nov 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/venus-remedies-gets-new-market-authorisations-for-drugs-in-vietnam/articleshow/125198399.cms

    ECONOMICTIMES
    09 Nov 2025
    Share Share
    Venus Remedies Launches Methotrexate, Cefuroxime, And Irinotecan
    Venus Remedies Launches Methotrexate, Cefuroxime, And Irinotecan

    06 Nov 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/venus-remedies-methotrexate-cefuroxime-and-irinotecan-enters-vietnam/

    EXPRESSPHARMA
    06 Nov 2025
    Share Share
    Stomach Cancer Awareness Month
    Stomach Cancer Awareness Month

    01 Nov 2025

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/9-news/215-stomach-cancer-awareness-month

    PRESS RELEASE
    01 Nov 2025
    Share Share
    Inhibrx Report Positive Ozekibart Data, Shares Cancer Updates
    Inhibrx Report Positive Ozekibart Data, Shares Cancer Updates

    24 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/inhibrx-biosciences-reports-positive-topline-results-from-its-registrational-trial-of-ozekibart-inbrx-109-in-chondrosarcoma-and-provides-updates-on-colorectal-cancer-and-ewing-sarcoma-expansion-cohorts-302593250.html

    PR NEWSWIRE
    24 Oct 2025
    Share Share
    Onivyde Regimen Linked to Long-Term Survival in Pancreatic Cancer
    Onivyde Regimen Linked to Long-Term Survival in Pancreatic Cancer

    31 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/31/3091404/0/en/Late-breaking-analysis-demonstrates-characteristics-associated-with-long-term-overall-survival-with-Onivyde-regimen-in-metastatic-pancreatic-adenocarcinoma.html

    GLOBENEWSWIRE
    31 May 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.